Literature DB >> 29432952

G.I. pros: Antimicrobial defense in the gastrointestinal tract.

Lawton K Chung1, Manuela Raffatellu2.   

Abstract

The gastrointestinal tract is a complex environment in which the host immune system interacts with a diverse array of microorganisms, both symbiotic and pathogenic. As such, mobilizing a rapid and appropriate antimicrobial response depending on the nature of each stimulus is crucial for maintaining the balance between homeostasis and inflammation in the gut. Here we focus on the mechanisms by which intestinal antimicrobial peptides regulate microbial communities during dysbiosis and infection. We also discuss classes of bacterial peptides that contribute to reducing enteric pathogen outgrowth. This review aims to provide a comprehensive overview on the interplay of diverse antimicrobial responses with enteric pathogens and the gut microbiota.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antimicrobial peptides; Bacteriocins; Enteric pathogens; Microbiota; Microcins; Nutritional immunity

Mesh:

Substances:

Year:  2018        PMID: 29432952      PMCID: PMC6087682          DOI: 10.1016/j.semcdb.2018.02.001

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  163 in total

1.  Klebsiella pneumoniae yersiniabactin promotes respiratory tract infection through evasion of lipocalin 2.

Authors:  Michael A Bachman; Jennifer E Oyler; Samuel H Burns; Mélissa Caza; François Lépine; Charles M Dozois; Jeffrey N Weiser
Journal:  Infect Immun       Date:  2011-05-16       Impact factor: 3.441

2.  Enhanced human beta-defensin-2 (hBD-2) expression by corticosteroids is independent of NF-kappaB in colonic epithelial cells (CaCo2).

Authors:  T Witthöft; C S Pilz; K Fellermann; M Nitschke; E F Stange; D Ludwig
Journal:  Dig Dis Sci       Date:  2005-07       Impact factor: 3.199

3.  Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3.

Authors:  O E Sørensen; P Follin; A H Johnsen; J Calafat; G S Tjabringa; P S Hiemstra; N Borregaard
Journal:  Blood       Date:  2001-06-15       Impact factor: 22.113

4.  The Bactericidal Lectin RegIIIβ Prolongs Gut Colonization and Enteropathy in the Streptomycin Mouse Model for Salmonella Diarrhea.

Authors:  Tsuyoshi Miki; Ryosuke Goto; Mayuka Fujimoto; Nobuhiko Okada; Wolf-Dietrich Hardt
Journal:  Cell Host Microbe       Date:  2017-01-19       Impact factor: 21.023

5.  Identification of the Escherichia coli K-12 Nramp orthologue (MntH) as a selective divalent metal ion transporter.

Authors:  H Makui; E Roig; S T Cole; J D Helmann; P Gros; M F Cellier
Journal:  Mol Microbiol       Date:  2000-03       Impact factor: 3.501

6.  Role of the high-affinity zinc uptake znuABC system in Salmonella enterica serovar typhimurium virulence.

Authors:  Susana Campoy; Mónica Jara; Núria Busquets; Ana M Pérez De Rozas; Ignacio Badiola; Jordi Barbé
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

7.  Molecular basis for self-assembly of a human host-defense peptide that entraps bacterial pathogens.

Authors:  Phoom Chairatana; Elizabeth M Nolan
Journal:  J Am Chem Soc       Date:  2014-09-12       Impact factor: 15.419

8.  The antimicrobial peptide cathelicidin protects mice from Escherichia coli O157:H7-mediated disease.

Authors:  Milan Chromek; Ida Arvidsson; Diana Karpman
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

9.  Ribonuclease 7, an antimicrobial peptide upregulated during infection, contributes to microbial defense of the human urinary tract.

Authors:  John David Spencer; Andrew L Schwaderer; Huanyu Wang; Julianne Bartz; Jennifer Kline; Tad Eichler; Kristin R DeSouza; Sunder Sims-Lucas; Peter Baker; David S Hains
Journal:  Kidney Int       Date:  2013-01-09       Impact factor: 10.612

10.  Turning defense into offense: defensin mimetics as novel antibiotics targeting lipid II.

Authors:  Kristen M Varney; Alexandre M J J Bonvin; Marzena Pazgier; Jakob Malin; Wenbo Yu; Eugene Ateh; Taiji Oashi; Wuyuan Lu; Jing Huang; Marlies Diepeveen-de Buin; Joseph Bryant; Eefjan Breukink; Alexander D Mackerell; Erik P H de Leeuw
Journal:  PLoS Pathog       Date:  2013-11-07       Impact factor: 6.823

View more
  12 in total

Review 1.  Mechanisms, biomarkers and targets for therapy in alcohol-associated liver injury: From Genetics to nutrition: Summary of the ISBRA 2018 symposium.

Authors:  Irina A Kirpich; Dennis R Warner; Wenke Feng; Swati Joshi-Barve; Craig J McClain; Devanshi Seth; Wei Zhong; Zhanxiang Zhou; Natalia A Osna; Kusum K Kharbanda
Journal:  Alcohol       Date:  2019-05-23       Impact factor: 2.405

2.  Dietary Nutrients Mediate Intestinal Host Defense Peptide Expression.

Authors:  Jianmin Wu; Ning Ma; Lee J Johnston; Xi Ma
Journal:  Adv Nutr       Date:  2020-01-01       Impact factor: 8.701

Review 3.  Microbiota in cerebrovascular disease: A key player and future therapeutic target.

Authors:  Shuichi Tonomura; Masafumi Ihara; Robert P Friedland
Journal:  J Cereb Blood Flow Metab       Date:  2020-04-20       Impact factor: 6.200

Review 4.  Microcins in Enterobacteriaceae: Peptide Antimicrobials in the Eco-Active Intestinal Chemosphere.

Authors:  Fernando Baquero; Val F Lanza; Maria-Rosario Baquero; Rosa Del Campo; Daniel A Bravo-Vázquez
Journal:  Front Microbiol       Date:  2019-10-09       Impact factor: 5.640

5.  Alterations in Intestinal Microbiota Composition in Mice Treated With Vitamin D3 or Cathelicidin.

Authors:  Yu Jiang; Yue Wan; Jing Li; Yueshui Zhao; Yongshun Ma; Jing Yu; Donghong Yuan; Shixin Xiang; Fukuan Du; Xu Wu; Mingxing Li; Yu Chen; Zhangang Xiao; Qinglian Wen; Wei Hu; Jing Shen
Journal:  Front Oncol       Date:  2021-12-23       Impact factor: 6.244

6.  Antimicrobial peptides and the gut microbiome in inflammatory bowel disease.

Authors:  John Gubatan; Derek R Holman; Christopher J Puntasecca; Danielle Polevoi; Samuel Js Rubin; Stephan Rogalla
Journal:  World J Gastroenterol       Date:  2021-11-21       Impact factor: 5.742

Review 7.  The Impact of Intestinal Microorganisms and Their Metabolites on Type 1 Diabetes Mellitus.

Authors:  Shu-Juan Zheng; Yi Luo; Jian-Hui Xiao
Journal:  Diabetes Metab Syndr Obes       Date:  2022-04-11       Impact factor: 3.249

8.  Pediatric nonalcoholic fatty liver disease and the microbiome: Mechanisms contributing to pathogenesis and progression.

Authors:  Nita H Salzman; Jeffrey B Schwimmer
Journal:  Curr Opin Endocr Metab Res       Date:  2021-05-17

Review 9.  Crosstalks Between Gut Microbiota and Vibrio Cholerae.

Authors:  Zixin Qin; Xiaoman Yang; Guozhong Chen; Chaiwoo Park; Zhi Liu
Journal:  Front Cell Infect Microbiol       Date:  2020-10-23       Impact factor: 5.293

Review 10.  Molecular Mechanisms of Microbiota-Mediated Pathology in Irritable Bowel Syndrome.

Authors:  Yoshiyuki Mishima; Shunji Ishihara
Journal:  Int J Mol Sci       Date:  2020-11-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.